Search results
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 1 day agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...
Moderna (NASDAQ:MRNA) Stock Price Down 2.2% on Insider Selling
ETF DAILY NEWS· 23 hours agoShares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) traded down 2.2% during mid-day trading on Wednesday following insider selling activity. 392,597 ...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 1 day agoModerna Inc. said Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed higher efficacy in adults age 18 and older ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. -...
Morningstar· 1 day agoNEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” ...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 4 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory...
State of Tennessee Treasury Department Boosts Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoState of Tennessee Treasury Department increased its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 27.5% in the fourth quarter, according to ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 2 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and olderHigher efficacy was observed in mRNA-1283 compared
Connectus Wealth LLC Purchases 2,016 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoConnectus Wealth LLC increased its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 90.8% during the fourth quarter, according to the ...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says - WSVN 7News...
7 News Miami· 4 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...